Recent developments in HIV research, treatment, and prevention have highlighted both remarkable progress and persistent challenges in controlling the virus worldwide. Innovations in antiretroviral therapies (ART), long-acting injectables, and preventive strategies have significantly improved patient outcomes and reduced transmission rates. However, disparities in access to treatment, emerging drug resistance, and gaps in public health infrastructure continue to impede efforts, particularly in low- and middle-income countries.